Grow Your Retirement Account With This Trade!
Whether you’re close to retirement or have barely begun your career, "How To Master the Retirement Trade" by expert Dave Aquino is the guide you’ve been waiting for.

Take advantage of a little known trade window and watch retirement come sooner than you ever thought possible.
Get your copy now!
Yung-Ping Yeh, insider at Vyant Bio
Yung-Ping Yeh Insider Alerts

Get notified the next time Yung-Ping Yeh buys or sells Vyant Bio stock. Enter your email address below to get our daily insider buying and selling report.

Yung-Ping Yeh Insider Information

Insider of Vyant Bio
Ping co-founded StemoniX in April 2014 and, since then, has served as its Chief Executive Officer and a Board Member. He cofounded the company after surviving blood cancer in 2013 - an experience that was the impetus for wanting to leverage his background in engineering, softare and manufacturing to find safer and more effective medicines for patients. Prior to co- founding StemoniX, Mr. Yeh commercialized multiple technologies to the tech industry. Highlights include serving as team lead for the first solid state drive product for Seagate Technology, leading the global partnership between Samsung and Seagate to create new flash technology and program managing the operating system software development for Dell enterprise storage systems. Mr. Yeh has successfully led through a multi-disciplinary approach for the last two decades of his career. Mr. Yeh holds a bachelor of science and master’s degree in mechanical engineering (nanotechnology emphasis) from University of California, San Diego, and a master’s degree in business administration from University of Minnesota’s Carlson School of Management. He has attained professional certifications in program and project management from the Project Management Institute and Mergers and Acquisitions from Northwestern’s Kellogg School of Management. Mr. Yeh serves on the UC San Diego Alumni Board of Directors and Medical Alley Board of Directors.

What is Yung-Ping Yeh's net worth?

The estimated net worth of Yung-Ping Yeh is at least $15,695.36 as of August 25th, 2021. Mr. Yeh owns 12,262 shares of Vyant Bio stock worth more than $15,695 as of January 20th. This net worth estimate does not reflect any other assets that Mr. Yeh may own. Learn More.

How do I contact Yung-Ping Yeh?

The corporate mailing address for Mr. Yeh and other Vyant Bio executives is 2370 State Route 70 Suite 310, Cherry Hill NJ, 08002. Vyant Bio can also be reached via phone at (201) 479-1357 and via email at [email protected]

Has Yung-Ping Yeh been buying or selling shares of Vyant Bio?

Yung-Ping Yeh has not been actively trading shares of Vyant Bio within the last three months. Most recently, on Monday, November 22nd, Yung-Ping Yeh bought 500 shares of Vyant Bio stock. The stock was acquired at an average cost of $2.05 per share, with a total value of $1,025.00.

Who are Vyant Bio's active insiders?

Vyant Bio's insider roster includes Marcus Boehm (Director), R. Fletcher (Director), Paul Hansen (Director), John Roberts (CEO), and Yung-Ping Yeh (Insider).

Are insiders buying or selling shares of Vyant Bio?

During the last twelve months, Vyant Bio insiders bought shares 16 times. They purchased a total of 115,687 shares worth more than $327,974.21. The most recent insider tranaction occured on December, 6th when Director Marcus Boehm bought 5,000 shares worth more than $8,450.00. Insiders at Vyant Bio own 15.0 % of the company.

Information on this page was last updated on 12/6/2021.

Yung-Ping Yeh Insider Trading History at Vyant Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Buy500$2.05$1,025.00View SEC Filing Icon  
8/25/2021Buy1,000$2.64$2,640.0012,262View SEC Filing Icon  
See Full Table

Yung-Ping Yeh Buying and Selling Activity at Vyant Bio

This chart shows Yung-Ping Yeh's buying and selling at Vyant Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vyant Bio Company Overview

Vyant Bio logo
Vyant Bio, Inc. is emerging as an advanced biotechnology drug discovery company. The firm is focused on human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of therapeutics for biopharma partners, as well as for its proprietary pipeline. The company with capabilities in data, science (both biology and chemistry), engineering, and regulatory, it rapidly identifying small and large molecule therapeutics and derisking decision making through multiple in silico, in vitro, and in vivo modalities. It leveraging these modalities, the company is able to capitalize on repurposed and novel compounds and then partner with others to further develop and commercialize valuable therapeutics and new treatments for patients. It operates two wholly-owned subsidiaries, StemoniX and vivoPharm. Vyant Bio was founded in 1999 and is headquartered in Cherry Hill, NJ.
Read More

Today's Range

Now: $1.28
Low: $1.23
High: $1.30

50 Day Range

MA: $1.64
Low: $1.21
High: $2.25

2 Week Range

Now: $1.28
Low: $1.20
High: $17.50

Volume

25,340 shs

Average Volume

67,578 shs

Market Capitalization

$37.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.17
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.